| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72b20d5e07095bcfd677a91882c9dc36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbca5f8d7c574e11a8775705e5aed5dc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2006-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3963bc210ee772bae45b5241f3e94b74 |
| publicationDate |
2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007019888-A2 |
| titleOfInvention |
Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases |
| abstract |
Compositions containing mesalamine or its derivatives and a co-agent effective for the treatment of gastrointestinal altered motility, sensitivity and secretion and abdominal viscera disorders including both functional and organic diseases are useful for the treatment of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Furthermore the present invention provides formulations and methods for treating IBS and IBD. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089492-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105412126-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580302-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023152674-A1 |
| priorityDate |
2005-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |